Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 August 2026 - 11:40

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/caprelsa

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters